Nomathemba Chandiwana to Drug Substitution
This is a "connection" page, showing publications Nomathemba Chandiwana has written about Drug Substitution.
Connection Strength
0,115
-
DORA: 48-week weight and metabolic changes in Black women with HIV, in a phase IIIb switch study from dolutegravir- or efavirenz- to doravirine-based first-line antiretroviral therapy. HIV Med. 2025 Jan; 26(1):81-96.
Score: 0,059
-
Regional variation in weight change after the transition to dolutegravir in Uganda and South Africa. AIDS. 2024 07 15; 38(9):1314-1322.
Score: 0,057